Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention
- 1 August 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (3) , 358-360
- https://doi.org/10.1016/j.amjcard.2004.04.035
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary interventionThe American Journal of Cardiology, 2004
- Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival: Results from the do tirofiban and reoprogive similar efficacy outcome trial (TARGET)Journal of the American College of Cardiology, 2003
- Soluble CD40 Ligand in Acute Coronary SyndromesNew England Journal of Medicine, 2003
- Scientific and therapeutic advances in antiplatelet therapyNature Reviews Drug Discovery, 2003
- Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary RevascularizationCirculation, 2001
- Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrelPlatelets, 2001
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- Activation of Monocyte/Macrophage Functions Related to Acute Atheroma Complication by Ligation of CD40Circulation, 1997
- Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction.Heart, 1988
- Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death.Circulation, 1986